BRIEF-Lilly, Astrazeneca to develop potentially disease-modifying Alzheimer's treatment By: Reuters: Company News December 09, 2016 at 07:20 AM EST * Lilly and Astrazeneca to develop second potentially disease-modifying treatment for Alzheimer's disease Read More >> Related Stocks: Astrazeneca Plc ADR Eli Lilly